Reference
McCloskey JK, et al. Outcomes with augmented hyper-CVAD (AHCVAD), a pediatric inspired HCVAD-based regimen, for adults younger than 50 years of age with newly diagnosed acute lymphoblastic leukemia (ALL). Blood 130 (Suppl. 1): 5050, Dec 2017 [abstract] - USA
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1695, 46 (2018). https://doi.org/10.1007/s40278-018-43874-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-43874-x